Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone action for improved blood sugar control and significant weight loss.

In sum, Clinic Secret Semaglutide Reviews demonstrate that an affordable, medically supervised plan can deliver meaningful ...

Wegovy launched here is to support Singapore’s efforts in improving population health: Novo Nordisk Read more at straitstimes ...

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some fear misuse of oral agents.

Semaglutide use was ascertained from pharmacy claims for single-dose prefilled pens, and participants were followed up for 6 months.

Semaglutide is the active ingredient in prefilled injectable pens sold under the brand names Ozempic and Wegovy, which many doctors prescribe for weight loss amid the obesity epidemic.

"Currently, Samsung Now has New S-Pen Tech, and Samsung is Ready to use it in the Ultra," they wrote in their tweet. Specifically, they say that Samsung will remove the S-Pen Digitizer.

Samsung is reportedly working on new S Pen or digitizer technology designed to overcome interference caused by magnetic cases and accessories.